Upcoming Webinar: SGLT2 Inhibitors for Transplant Recipient Kids

October 13, 2025 | 3 PM ET / 12 PM PT | Online

You may have heard the name, but what exactly are SGLT2 inhibitors—and why are they important for children who’ve had a transplant? This class of medicines, originally developed for diabetes, has been shown to help protect both kidney and heart health, reducing the chance of diabetes, heart failure, and other complications.

Join experts in transplant pharmacy, cardiology, and nephrology as they explain in simple, practical terms what these drugs can mean for kids and families. Whether you’re a caregiver wanting to better understand your child’s medications or a practitioner looking for updates, this session will give you the knowledge you need.

👉 Register here: bit.ly/TFSGLT2

Speakers:

• Mary Moss Chandran, PharmD – Transplant Pharmacy, UNC

• Joseph Spinner, MD FAAP – Cardiology, Texas Children’s Hospital

• Alexander Kula, MD – Nephrology, Lurie Children’s Hospital of Chicago